ViaCell, Inc.

About ViaCell, Inc.

ViaCell is a biotechnology company dedicated to enabling the widespread application of human cells as medicine.

The Company markets ViaCord(R), a product offering through which families can preserve their baby’s umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases.ViaCell also conducts research and development primarily to investigate other potential therapeutic uses of umbilical cord blood-derived stem cells and on technology for expanding populations of these cells.

ViaCell’s pipeline is focused in the areas of cancer, cardiac disease, diabetes and fertility.

In March 2007, ViaCell commenced a pivotal clinical trial evaluating ViaCyte, an investigational product being studied for the cryopreservation and thawing of human oocytes for use during assisted reproductive technology.

ViaCell is headquartered in Cambridge, Massachusetts with a processing and storage facility in Hebron, Kentucky.